Computed tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy

被引:22
作者
Cooper, Robert M. [1 ]
Binukrishnan, Sukumaran R. [1 ]
Shahzad, Adeel [1 ]
Hasleton, Jonathan [1 ]
Sigwart, Ulrich [2 ]
Stables, Rodney H. [1 ]
机构
[1] Liverpool Heart & Chest Hosp, Inst Cardiovasc Med & Sci, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[2] Univ Geneva, Geneva, Switzerland
关键词
alcohol septal ablation; computed tomography; hypertrophic cardiomyopathy; MYOCARDIAL ABLATION; MULTICENTER; SURVIVAL;
D O I
10.4244/EIJ-D-15-00159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Alcohol septal ablation (ASA) is an established treatment option in hypertrophic obstructive cardiomyopathy (HOCM). ASA is ineffective in some: inaccurate infarct and inability to identify a vessel contribute. We aimed to improve accuracy of infarct using CT angiography guidance and provide a more predictable and satisfactory outcome. Methods and results: Twenty-one successive patients with symptomatic LVOT obstruction refractory to medication underwent CT angiography planning to guide ASA. CT was performed using a dual-source CT system. Alcohol was delivered to the artery identified from CT: in 17/21 this was a sub-branch of a septal artery, in 2/21 the septal vessel was identified from the circumflex artery. Peak gradient improved from 98 (IQR 89.50-111.50) mmHg to 14 (1QR 8.50-22) mmHg (p=0.003). Systolic anterior motion (SAM) improved in 18/20 patients. NYIIA class improved by >= 1 in 18/20. Peak VO2 improved from 79.19% of predicted value (+/- 14.01) to 91.62% (+/- 12.02) predicted (p<0.0001). Success at the first procedure is greater with CT guidance, 17/20 vs. 50/75 with traditional methods (pre-CT guidance) (p=0.02); 9/20 had six-month CMR with target septum infarct in all. ASA-related RBBB reduced from 62% to 13% (p=0.0004). Conclusions: CT angiography planning improves localisation of infarct and procedural success at the first attempt in ASA when compared to traditional methods. Follow-up to six months suggests a symptomatic, functional and haemodynamic improvement.
引用
收藏
页码:E2194 / E2203
页数:10
相关论文
共 17 条
[1]  
Cooper RM, 2013, INTERVENT CARDIOL, V5, P427
[2]   Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSoundA® technology to guide ablation [J].
Cooper, Robert M. ;
Shahzad, Adeel ;
Hasleton, Jonathan ;
Digiovanni, Joseph ;
Hall, Mark C. ;
Todd, Derick M. ;
Modi, Simon ;
Stables, Rodney H. .
EUROPACE, 2016, 18 (01) :113-120
[3]  
Cooper RM, 2015, J INVASIVE CARDIOL, V27, P301
[4]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[5]   Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy - Results with respect to intraprocedural myocardial contrast echocardiography [J].
Faber, L ;
Seggewiss, H ;
Gleichmann, U .
CIRCULATION, 1998, 98 (22) :2415-2421
[6]   Alcohol septal ablation for hypertrophic cardiomyopathy: Indications and technique [J].
Holmes, DR ;
Valeti, US ;
Nishimura, RA .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2005, 66 (03) :375-389
[7]   Long-Term Outcome of Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy A Scandinavian Multicenter Study [J].
Jensen, Morten Kvistholm ;
Almaas, Vibeke Marie ;
Jacobsson, Linda ;
Hansen, Peter Riis ;
Havndrup, Ole ;
Aakhus, Svend ;
Svane, Bertil ;
Hansen, Thomas Fritz ;
Kober, Lars ;
Endresen, Knut ;
Eriksson, Maria J. ;
Jorgensen, Erik ;
Amlie, Jan Peder ;
Gadler, Fredrik ;
Bundgaard, Henning .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (03) :256-265
[8]   Use of Intraprocedural CT Imaging to Guide Alcohol Septal Ablation of Hypertrophic Cardiomyopathy in the Cardiac Catheterization Laboratory [J].
Krishnaswamy, Amar ;
Tuzcu, E. Murat ;
Kapadia, Samir R. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (06) :991-994
[9]   Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience [J].
Kuhn, Horst ;
Lawrenz, Thorsten ;
Lieder, Frank ;
Leuner, Christian ;
Strunk-Mueller, Claudia ;
Obergassel, Ludger ;
Bartelsmeier, Markus ;
Stellbrink, Christoph .
CLINICAL RESEARCH IN CARDIOLOGY, 2008, 97 (04) :234-243
[10]   Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy [J].
Maron, MS ;
Olivotto, I ;
Betocchi, S ;
Casey, SA ;
Lesser, JR ;
Losi, MA ;
Cecchi, F ;
Maron, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (04) :295-303